Prudential Financial’s Prime Medicine PRME Stock Holding History

Prudential Financial’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.4K	Hold	14,755	–	–	﹤0.01%	2410
2026 Q1	$51.3K	Buy	+14,755	New	+$56.2K	﹤0.01%	2310

Other funds holding PRME

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Prudential Financial's PRME Position: Q2 2026 in Review

Prudential Financial held its Prime Medicine (PRME) position steady in Q2 2026 at 14,755 shares worth $54.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

Prudential Financial first reported a position in PRME in Q1 2026 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

Prudential Financial held 14,755 shares of Prime Medicine worth $54.4K as of Q2 2026.
Prudential Financial left its Prime Medicine share count unchanged in Q2 2026.
Prime Medicine made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2410 holding.
Prudential Financial first reported a position in Prime Medicine in Q1 2026 and has held it in 2 quarters since.
188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.